Summary
Selective delivery of drugs or imaging dyes to tumor is the central challenge for improving existing therapy and diagnosis of cancer. Phage display of random peptides has been used to identify homing peptides that are specific to tumor cells or tumor blood vessels. These homing peptides can be conjugated with imaging agents or therapeutic drugs and may be a promising tool for affinity-based targeted delivery of imaging agents and drugs. This chapter describes the procedures for phage display selection of peptides that selectively bind to bladder tumor cells and home to tumor tissues in vivo. It also describes the application of the tumor-specific peptide to the detection of bladder cancer cells in the patient urine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reuter, V. E. and Melamed, M. R. (1989) The lower urinary tract. New York, Raven Press, pp. 1355–92.
Michaud, D. S. (2007) Chronic inflammation and bladder cancer Urol Oncol 25, 260–8.
Raghavan, D., Shipley, W. U., Garnick, M. B., Russell, P. J., and Richie, J. P. (1990) Biology and management of bladder cancer N Engl J Med 322, 1129–38.
Wiener, H. G., Mian, C., Haitel, A., Pycha, A., Schatzl, G., and Marberger, M. (1998) Can urine bound diagnostic tests replace cystos-copy in the management of bladder cancer? J Urol 159, 1876–80.
Ruoslahti, E. (2002) Specialization of tumor vasculature Nat Rev Cancer 2, 83–90.
Pasqualini, R. and Ruoslahti, E. (1996) Organ targeting in vivo using phage display peptide libraries Nature 380, 364–6.
Lee, S. M., Lee, E. J., Hong, H. Y., Kwon, M. K., Kwon, T. H., Choi, J. Y., Park, R. W., Kwon, T. G., Yoo, E. S., Yoon, G. S., Kim, I. S., Ruoslahti, E., and Lee, B. H. (2007) Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display Mol Cancer Res 5, 11–19.
Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228, 1315–17.
Pasqualini, R., Koivunen, E., and Ruoslahti, E. (1997) Alpha v integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol 15, 542–6.
Ladner, R. C., Sato, A. K., Gorzelany, J., and de Souza, M. (2004) Phage display-derived peptides as therapeutic alternatives to antibodies Drug Discov Today 9, 525–9.
Hoffman, J. A., Laakkonen, P., Porkka, K., Ber-nasconi, M., and Ruoslahti, E. (2004) In vivo and ex vivo selections using phage-displayed libraries In: T. Clackson, Lowman, H. B. (ed.), Phage display, 1st edition, Vol. 266. New York, Oxford University Press, pp. 171–92.
Ohyama, C., Kawamura, S., Satoh, M., Saito, S., Yoshikawa, K., Hoshi, S., and Orikasa, S. (1997) Endoscopic observation for detection and monitoring of N-butyl-N-(4-hydroxy-butyl)nitrosamine-induced bladder tumor in rats Urol Res 25, 183–6.
Azzazy, H. M. and Highsmith, W. E., Jr. (2002) Phage display technology: clinical applications and recent innovations Clin Bio-chem 35, 425–45.
Acknowledgments
This work was supported by the Ministry of Science and Technology (F104AA010003-06A0101-00310), grant No. RTI04-01-01 from the Regional Technology Innovation Program of the Ministry of Knowledge Economy (MKE), and Brain Korea 21 Project in 2006.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Seung-Min, L., Gil-Suk, Y., Eun-Sang, Y., Tae-Gyun, K., In-San, K., Byung-Heon, L. (2009). Application of Phage Display to Discovery of Tumor-Specific Homing Peptides: Developing Strategies for Therapy and Molecular Imaging of Cancer. In: Kozlov, S.V. (eds) Inflammation and Cancer. Methods in Molecular Biology™, vol 512. Humana Press. https://doi.org/10.1007/978-1-60327-530-9_20
Download citation
DOI: https://doi.org/10.1007/978-1-60327-530-9_20
Publisher Name: Humana Press
Print ISBN: 978-1-60327-529-3
Online ISBN: 978-1-60327-530-9
eBook Packages: Springer Protocols